Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Cross-bridge Cycle

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Chemical Synapses

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Role of adrenergic neuronal activity in the yawning induced by tacrine and NIK-247 in rats.

Pharmacology, biochemistry, and behavior·1992

Same author

Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.

Pharmacology, biochemistry, and behavior·1992

Same author

[MR imaging of stereotactic thalamotomy using radiofrequency methods].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992

Same author

Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes.

Circulation research·1992

Same author

New technique using intraductal ultrasonography for the diagnosis of diseases of the pancreatobiliary system.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·1992

Same author

[Japanese clinical statistical data of patients with Guillain-Barre syndrome].

Nihon rinsho. Japanese journal of clinical medicine·1992

Search research articles

Related Experiment Video

Updated: May 12, 2026

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Published on: January 11, 2014

Neurogenic FSH muscular atrophy.

¹Department of Allied Health Sciences, Faculty of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Muscle & Nerve. Supplement

|April 12, 2013

Summary

This summary is machine-generated.

Neurogenic facioscapulohumeral atrophy is distinct from facioscapulohumeral muscular dystrophy. This study investigates if the causative genes for both conditions are the same or different.

More Related Videos

Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices

Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices

Published on: September 7, 2021

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Related Experiment Videos

Last Updated: May 12, 2026

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Published on: January 11, 2014

Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices

Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices

Published on: September 7, 2021

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Area of Science:

Neurology
Genetics
Muscular Disorders

Background:

Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder affecting muscles.
Neurogenic facioscapulohumeral (FSH) muscular atrophy presents similarly but has a different underlying pathology.
The genetic basis differentiating these conditions remains unclear.

Purpose of the Study:

To determine if the gene(s) responsible for neurogenic FSH muscular atrophy are identical to those causing FSH muscular dystrophy.
To clarify the genetic etiology distinguishing these two distinct neuromuscular disorders.

Main Methods:

Comparative genetic analysis.
Differential gene expression profiling.
Clinical phenotyping of affected individuals.

Main Results:

Preliminary findings suggest potential genetic divergence between the two conditions.
Further investigation is required to pinpoint specific genetic markers.

Conclusions:

Neurogenic FSH muscular atrophy and FSH muscular dystrophy may involve distinct genetic factors.
Identifying these genetic differences is crucial for accurate diagnosis and potential therapeutic strategies.